Ayd BioPharma Consulting Group LLC “Ayd Group” was founded in 2015. Ayd Group is an entrepreneurial-minded consulting firm that provides technical support and expert advice to Life Sciences companies regulated by the U.S. Food and Drug Administration (“FDA”) as well as international regulatory bodies. Our focus sectors are: • Pharmaceuticals • Biologics/Biosimilar • Drug/Device Combination Products We help start-ups, mid-size and Big Pharma, to manage and overcome complicated product development issues and understand burden-some regulatory pathways. We translate the complexities of regulatory and research disciplines into understandable terms for life science entrepreneurs, company executives and financial investors who play pivotal roles either by investing in or developing/acquiring a new drug or medical device. Our primary focus is providing end to end services in the following areas. • CMC Strategy &Technical Support • Preclinical & Regulatory Science • Clinical and Regulatory Affairs Support • Quality Systems & Compliance • Product Lifecycle Management • Due Diligence Examples of who our clients are include: • Early-stage companies finishing up pre-clinical toxicology work and needing insight to get to clinical stage • Pharmaceutical Companies - Branded/Generic drugs - Rare Disease drugs - Orphan designated drugs - FDA Regulated Prescription drugs sourced from cannabis • Biologics/Biosimilar Companies • Medical Device Companies - Combination Products • Financial Investors (Individual or institutional) • Law Firms • Contract Development & Manufacturing Organizations (CMO or CDMO)